The Affordable Medicines Program continued under martial law

The Ministry of Public Health reports, that the Affordable Medicines Program continues its existence. As before, patients who need outpatient treatment for cardiovascular diseases, type I/II diabetes, diabetes insipidus, bronchial asthma, mental and behavioral disorders, and epilepsy can receive free of charge or against a small surcharge the medicines they do need included in the program

To ensure patients' access to these medicines, the respective procedures for drugs obtaining during the war were simplified, namely, now patients can receive "affordable medicines" both by electronic and paper prescription. You can get a prescription in paper form from a doctor who provides primary health care, regardless of whether you did conclude a medical aid declaration on their name.

The largest* domestic pharmaceutical company "Darnitsa" is represented in the program "affordable medicines" by eight medicines positions bearing the international name (IMN), three of which are included in 100% compensation list (that is, the patient receives them free of charge). These are drugs that fight cardiovascular diseases (Amiodarone-Darnitsa, Verapamil-Darnitsa, Enalapril-Darnitsa, Nifedipine-Darnitsa), antiepileptic drugs (Carbamazepine-Darnitsa), Potassium-sparing and highly active diuretics (Spironolactone-Darnitsa, Furosemide-Darnitsa).** 

The  StateMedService emphasizes that now there is no threat of a shortage with medicines. There is a problem in the active hostilities hot spots but the state applies all efforts at providing humanitarian convoys to those locations. In certain regions, due to increased demand, the number of orders for medicines increases accordingly. Domestic manufacturers continue the production. Thus, the pharmaceutical company Darnitsa has been supporting the country's pharmaceutical industry since the first days of the war. During the military aggression, Darnitsa handed over to medical institutions and volunteer organizations free of charge almost 700 thousand packages of medicines worth more than UAH 30 million.

"Since the first day of the war, Darnitsa has been supporting the State pharm defense, working closely with the Ministry of Public Health, helping the Armed Forces of Ukraine and volunteer organizations. The Company's participation in the Affordable Medicines Program is part of this process. To help Ukrainians find medicines* in pharmacies across the country, we have opened a free hotline where you can contact about any medicines, and not only produced by Darnitsa. Joining efforts we'll win!",- noted Dmytro Shymkiv, Chairman of the Darnitsa Group Board of Directors.

* Darnitsa hotline for medicines searching, phone number: 0800407877

Service accessible: Monday-Sunday 8:00 a.m. - till 8:00 p.m.

Reference

PJSC pharmaceutical company "Darnitsa" was founded in 1930. Since 1998, Darnitsa is the leader in Ukrainian pharma industry in terms of drug production in kind. Strategic areas of products portfolio development include cardiology, neurology, and pain management.

*in physical terms Proxima Research, 2021-2022

**Amiodaron-Darnitsa RP № UA/6506/01/01, Verapamil-Darnitsa RP № UA/3582/01/01, №UA/3582/01/02, Enalapril-Darnitsa RP № UA/9020/01/01, Nifedipine-Darnitsa RP №UA/4738/02/01, Carbamazepine-Darnitsa RP № UA/2579/01/01, Spironolactone-Darnitsa RP № UA/0808/01/01,№ UA/0808/01/02, Furosemide-Darnitsa RP № UA/2353/01/01.

***The above information is targeted exclusively for distribution in specialized publications intended for medical institutions and doctors, as well as at conferences and seminars on medical topics.